Cytokine storm: Acalabrutinib assists in calming down in COVID-19 patients in study
by Press Release from Outbreak News Today on (#54DQY)
The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized for the treatment of severe COVID-19, according to a new study by Mark Roschewski and colleagues. The drug was administered to 11 patients on [...]
The post Cytokine storm: Acalabrutinib assists in calming down in COVID-19 patients in study appeared first on Outbreak News Today.